Literature DB >> 23899565

Deubiquitylases from genes to organism.

Michael J Clague1, Igor Barsukov, Judy M Coulson, Han Liu, Daniel J Rigden, Sylvie Urbé.   

Abstract

Ubiquitylation is a major posttranslational modification that controls most complex aspects of cell physiology. It is reversed through the action of a large family of deubiquitylating enzymes (DUBs) that are emerging as attractive therapeutic targets for a number of disease conditions. Here, we provide a comprehensive analysis of the complement of human DUBs, indicating structural motifs, typical cellular copy numbers, and tissue expression profiles. We discuss the means by which specificity is achieved and how DUB activity may be regulated. Generically DUB catalytic activity may be used to 1) maintain free ubiquitin levels, 2) rescue proteins from ubiquitin-mediated degradation, and 3) control the dynamics of ubiquitin-mediated signaling events. Functional roles of individual DUBs from each of five subfamilies in specific cellular processes are highlighted with an emphasis on those linked to pathological conditions where the association is supported by whole organism models. We then specifically consider the role of DUBs associated with protein degradative machineries and the influence of specific DUBs upon expression of receptors and channels at the plasma membrane.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23899565     DOI: 10.1152/physrev.00002.2013

Source DB:  PubMed          Journal:  Physiol Rev        ISSN: 0031-9333            Impact factor:   37.312


  207 in total

Review 1.  USP7: Structure, substrate specificity, and inhibition.

Authors:  Alexandra Pozhidaeva; Irina Bezsonova
Journal:  DNA Repair (Amst)       Date:  2019-02-16

Review 2.  Using protein motion to read, write, and erase ubiquitin signals.

Authors:  Aaron H Phillips; Jacob E Corn
Journal:  J Biol Chem       Date:  2015-09-09       Impact factor: 5.157

3.  Inhibition of Ubiquitin-Specific Protease 14 Suppresses Cell Proliferation and Synergizes with Chemotherapeutic Agents in Neuroblastoma.

Authors:  Yang Yu; Yanling Zhao; Yihui Fan; Zhenghu Chen; Hui Li; Jiaxiong Lu; Kevin Guo; Sarah E Woodfield; Sanjeev A Vasudevan; Jianhua Yang; Jed G Nuchtern
Journal:  Mol Cancer Ther       Date:  2019-04-08       Impact factor: 6.261

4.  Phosphorylation of the type II transmembrane serine protease, TMPRSS13, in hepatocyte growth factor activator inhibitor-1 and -2-mediated cell-surface localization.

Authors:  Andrew S Murray; Fausto A Varela; Thomas E Hyland; Andrew J Schoenbeck; Jordan M White; Lauren M Tanabe; Sokol V Todi; Karin List
Journal:  J Biol Chem       Date:  2017-07-14       Impact factor: 5.157

5.  Characterization of the deubiquitinating activity of USP19 and its role in endoplasmic reticulum-associated degradation.

Authors:  Jin-Gu Lee; Woong Kim; Steven Gygi; Yihong Ye
Journal:  J Biol Chem       Date:  2013-12-19       Impact factor: 5.157

6.  USP5 Is Dispensable for Monoubiquitin Maintenance in Drosophila.

Authors:  Gorica Ristic; Wei-Ling Tsou; Ermal Guzi; Adam J Kanack; Kenneth Matthew Scaglione; Sokol V Todi
Journal:  J Biol Chem       Date:  2016-02-25       Impact factor: 5.157

Review 7.  Otubain 1: a non-canonical deubiquitinase with an emerging role in cancer.

Authors:  Matthew Saldana; Kacey VanderVorst; Anastasia L Berg; Hyun Lee; Kermit L Carraway
Journal:  Endocr Relat Cancer       Date:  2019-01-01       Impact factor: 5.678

8.  Modulation of conformational equilibrium by phosphorylation underlies the activation of deubiquitinase A.

Authors:  Ashish Kabra; Efsita Rumpa; Ying Li
Journal:  J Biol Chem       Date:  2020-02-18       Impact factor: 5.157

9.  The deubiquitinase ataxin-3 requires Rad23 and DnaJ-1 for its neuroprotective role in Drosophila melanogaster.

Authors:  Wei-Ling Tsou; Michelle Ouyang; Ryan R Hosking; Joanna R Sutton; Jessica R Blount; Aaron A Burr; Sokol V Todi
Journal:  Neurobiol Dis       Date:  2015-05-22       Impact factor: 5.996

Review 10.  Ubiquitin-proteasome signaling in lung injury.

Authors:  Natalia D Magnani; Laura A Dada; Jacob I Sznajder
Journal:  Transl Res       Date:  2018-04-23       Impact factor: 7.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.